Urohealth Plans Clinical Trials
- Share via
COSTA MESA — Urohealth Systems Inc., which makes disposable and reusable medical products, said it has received federal conditional approval that will allow it to begin clinical trials for its RelaX product, a female urinary incontinence device.
As part of the approval, the company said it will respond within 45 days to comments from the U.S. Food and Drug Administration.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
